Eli Lilly has rolled out Foundayo, its oral GLP-1 pill, directly to consumers through its LillyDirect cash-pay channel, as well as to telehealth providers and pharmacies across the U.S. The drug is a ...

The U.S. Food and Drug Administration has approved Eli Lilly’s new weight-loss GLP-1 pill, orforglipron, which will be sold as Foundayo. In a clinical trial, participants who received the highest dose ...

Federal regulators on Wednesday approved Eli Lilly's new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions. The Food and Drug Administration granted ...

Eli Lilly, the Indianapolis-based pharmaceutical company, officially received approval from the Food and Drug Administration for a new weight-loss pill on April 1. The company shared in a press ...

Add Yahoo as a preferred source to see more of our stories on Google. Eli Lilly, the Indianapolis-based pharmaceutical company, officially received approval from the Food and Drug Administration for a ...

The Food and Drug Administration granted expedited approval on Wednesday to Eli Lilly’s new weight-loss pill, a medication used to treat obesity and other weight-related conditions. Orforglipron is a ...

The U.S. Food and Drug Administration on Wednesday gave its approval to Eli Lilly’s GLP-1 weight loss pill. The daily pill, called Foundayo, is the second oral GLP-1 product to reach the market over ...

Add Yahoo as a preferred source to see more of our stories on Google. The FDA has approved two GLP-1 oral medications, including one by Eli Lilly on Wednesday. File Photo by Jim Lo Scalzo/EPA April 1 ...

The US Food and Drug Administration on Wednesday approved a new obesity pill called Foundayo. Taken once daily, the pill is made by pharmaceutical company Eli Lilly, which also manufactures the ...

April 1 (UPI) --The Food and Drug Administration on Wednesday approved Eli Lilly's pill version of a GLP-1 medication for weight loss, making it the second company to offer a non-injectable version of ...